• 6-MP is further metabolized by hypoxanthine-guanine phosphoribosyltransferase (HGPRT) into 6-thioguanosine-5′-phosphate (6-thio-GMP) and 6-thioinosine monophosphate (6-thio-IMP), both inhibit nucleotide conversions and de novo purine synthesis. (illnesshacker.com)
  • A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. (lookformedical.com)
  • The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides. (lookformedical.com)
  • Nucleotides are very important as cosubstrates in metabolism. (heresy.is)
  • Immunosuppression likely occurs because of the ability of the drug to inhibit purine biosynthesis. (illnesshacker.com)
  • Azathioprine is converted into 6-mercaptopurine in the body where it blocks purine metabolism and DNA synthesis. (illnesshacker.com)
  • Azathioprine antagonizes purine metabolism and may inhibit synthesis of DNA, RNA, and proteins. (illnesshacker.com)
  • Azathioprine acts to inhibit purine synthesis necessary for the proliferation of cells, especially leukocytes and lymphocytes. (illnesshacker.com)
  • Azathioprine inhibits DNA synthesis and, as a purine antimetabolite, exerts its effect on activated lymphocytes, which requires purines during their proliferative phase. (illnesshacker.com)
  • It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. (lookformedical.com)
  • Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism. (lookformedical.com)
  • An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. (targetmol.com)
  • It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in. (targetmol.com)
  • It may also interfere with cellular metabolism and inhibit mitosis. (illnesshacker.com)
  • A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. (lookformedical.com)
  • It also acts as an antimetabolite on some simpler organisms. (nih.gov)
  • An antimetabolite antineoplastic agent with immunosuppressant properties. (bvsalud.org)
  • Nelarabine is a purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments. (drugbank.com)
  • It is a derivative of mercaptopurine (2-amino-6-mercaptopurine) and, like its parent molecule, inhibits purine metabolism, thus blocking DNA, RNA and subsequent protein synthesis. (nih.gov)
  • ALT elevations as well as myelotoxicity have been linked to higher levels of methyl-mercaptopurine, a product of one of the metabolic pathways of thioguanine metabolism. (nih.gov)
  • It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. (bvsalud.org)
  • Identification of genetic variations that affect activation and metabolism may permit the development of individualized therapy that optimize effectiveness and minimize toxicity. (basicmedicalkey.com)
  • The term metabolism refers to the many chemical reactions that take place in our bodies. (cancerquest.org)
  • 14 Nelarabine preferentially accumulates in T-cells since T-cells have a higher expression of enzymes that convert nelarabine to the active purine analog form, making them effective against T-cells malignancies. (drugbank.com)
  • The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. (lookformedical.com)
  • The presence of the 'decoy' antimetabolites prevents the cells from carrying out vital functions and the cells are unable to grow and survive. (cancerquest.org)
  • Thioguanine (also referred to as 6-thioguanine and as tioguanine) is a purine analogue that is used in the therapy of acute and chronic myelogenous leukemias. (nih.gov)